Emerging Company Profile
BigHat: AI for antibody optimization beyond target engagement
Emerging Company Profile: $19M a16z-led round to support antibody optimization platform
BigHat debuts with a $19 million a16z-led A round and a platform combining machine learning with lab assays to rapidly engineer antibodies with optimal biophysical and functional properties.
Feb 11, 2021 | 1:31 AM GMT